How Labs Are Meeting the Challenges of the Post-Pandemic World
The expiration of the federal Public Health Emergency for COVID-19 provides new impetus for lab innovation in the post-pandemic world.
Read MorePosted by Chris Wolski | May 9, 2023 | Covid 19, Molecular Diagnostics, POC Rapid Assays |
The expiration of the federal Public Health Emergency for COVID-19 provides new impetus for lab innovation in the post-pandemic world.
Read MorePosted by Melanie Hamilton-Basich | Apr 24, 2023 | Molecular Diagnostics |
The LENA Molecular Dx Leukemia Platform is a core group of 12 molecular diagnostic tests that can be processed on a standard qPCR machine.
Read MorePosted by Chris Wolski | Mar 20, 2023 | Leukemia, Molecular Diagnostic Analyzers |
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read MorePosted by Andy Lundin | Mar 10, 2023 | Leukemia |
QIAGEN and Servier are partnering to develop a CDx test for TIBSOVO, an isocitrate dehydrogenase-1 inhibitor indicated for AML treatment.
Read MorePosted by Andy Lundin | Mar 9, 2023 | Leukemia |
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read More